iBio
IBIO
#10074
Rank
ยฃ20.25 M
Marketcap
ยฃ0.90
Share price
-6.25%
Change (1 day)
-55.62%
Change (1 year)

Revenue for iBio (IBIO)

Revenue in 2025 (TTM): ยฃ0.3 Million

According to iBio's latest financial reports the company's current revenue (TTM ) is ยฃ0.3 Million. In 2024 the company made a revenue of ยฃ0.29 Million an increase over the revenue in the year 2023 that were of ยฃ0.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for iBio from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.3 M2.08%
2024 ยฃ0.29 M661.41%
2023 ยฃ0.03 M-97.45%
2022 ยฃ1.53 M54.96%
2021 ยฃ0.99 M-41.95%
2020 ยฃ1.71 M28.58%
2019 ยฃ1.32 M95.17%
2018 ยฃ0.68 M100.65%
2017 ยฃ0.33 M-51.5%
2016 ยฃ0.7 M8.2%
2015 ยฃ0.64 M-27.57%
2014 ยฃ0.89 M138.93%
2013 ยฃ0.37 M-45.71%
2012 ยฃ0.68 M-0.35%
2011 ยฃ0.69 M
2010 N/A-100%
2009 ยฃ0.28 M-65.54%
2008 ยฃ0.83 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Genocea Biosciences
GNCA
ยฃ1.43 M 377.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.56 B 187,575.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 23,037,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
ยฃ46.99 M 15,550.00%๐Ÿ‡บ๐Ÿ‡ธ USA